secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001159036-23-000017
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Halozyme discloses minimal SVB exposure; deposits insured, custodial accounts at separate banks
--------------------------------------------------------------------------------

- Cash deposit at SVB under $250,000 FDIC limit as of March 10, 2023.
- Majority of cash and investments held in custodial accounts at independent institutions; SVB is agent only.
- SVB is a lender on $575M credit facility with $39M commitment; no current draws and no plans to draw.
- Treasury/Fed/FDIC joint statement ensures all depositors are fully protected; money available March 13.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903623000017/0001159036-23-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903623000017/halo-20230310.htm
  HTML page:      https://secwatch.observer/filing/0001159036-23-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer